trending Market Intelligence /marketintelligence/en/news-insights/trending/gvgm2s_pqn0ynzqf6xut4a2 content esgSubNav
In This List

Former GSK exec joins Aclaris Therapeutics as chief medical officer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Former GSK exec joins Aclaris Therapeutics as chief medical officer

Aclaris Therapeutics Inc. appointed David Gordon chief medical officer.

Gordon recently served as senior vice president and head of dermatology research at GlaxoSmithKline PLC.

Wayne, Pa.-based Aclaris Therapeutics develops therapies in the areas of medical and aesthetic dermatology as well as immunology.